Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders [Phase 2]
A Phase 2 clinical trial is evaluating gabapentin for restoring GABA/glutamate homeostasis in people with co-occurring bipolar disorder and …
-
FDA approval · 2025-07-01FDA Approved: CARBAMAZEPINE — Supplemental Application (Bionpharma Inc.,)
FDA approved a supplemental application for carbamazepine from Bionpharma Inc. This action confirms regulatory clearance for the product und…
-
CLINICAL_TRIALS other · 2025-07-01Clinical Trial Update: Study of Lumateperone in the Treatment of Patients With Bipolar Mania [Phase 3]
Lumateperone is being studied in a Phase 3 trial for manic episodes in bipolar disorder, and the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Study of Lumateperone in the Acute Treatment of Patients With Bipolar Mania [Phase 3]
A Phase 3 clinical trial is evaluating lumateperone for acute treatment of mania in bipolar disorder and is currently recruiting.
-
FDA approval · 2025-07-01FDA Approved: LURASIDONE HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Lurasidone Hydrochloride from Macleods Pharmaceuticals Limited, authorizing the generic product.…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: A Novel Psychological Intervention for Adults With Bipolar Disorder and Attention Deficit Hyperactivity Disorder Comorbidity (VECTOR) [NA]
A clinical trial update describes a novel psychological intervention for adults with comorbid bipolar disorder and ADHD (VECTOR), which is n…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Imaging mGluR5 and Synaptic Density in Psychiatric Disorders
A Yale University clinical trial is evaluating imaging of metabotropic glutamate receptor 5 (mGluR5) and synaptic density in Major Depressiv…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Neuro-computational Study of Thymic Fluctuations in Mood Disorders [NA]
Clinical trial update for a neuro-computational study of thymic fluctuations in mood disorders, currently recruiting at Centre Hospitalier S…
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: A Cohort Study of Disease Prediction Model for High-risk Population With Bipolar Disorder
This document notes a cohort study developing a disease-prediction model for a high-risk population with bipolar disorder, currently recruit…
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: Optimal Electrical Stimulus During Electroconvulsive Therapy [Phase 4]
Phase 4 clinical trial investigating the optimal electrical stimulus during electroconvulsive therapy for major depressive disorder and bipo…
-
CLINICAL_TRIALS trial_result · 2025-06-22Clinical Trial Update: Pediatric Bipolar Registry
A completed pediatric bipolar registry study sponsored by The University of Texas Health Science Center, Houston, evaluating clinical featur…
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression [Phase 1]
A Phase 1 clinical trial update describes evaluating adjunctive allogeneic mesenchymal stem cells for treatment-resistant bipolar depression…
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: Mental Health Impact of the COVID-19 Pandemic on Amish and Mennonite Participants in AMBiGen
The AMBiGen trial, sponsored by the National Institute of Mental Health, completed an investigation into how the COVID-19 pandemic affected …
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: 'Thriving With Bipolar Disorder': Co-design and Evaluation of a Peer-Led Education Program Focused on Quality of Life [NA]
A clinical trial update describes a co-designed, peer-led education program for individuals with bipolar disorder, focused on improving qual…
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: Risk of Mental Health Conditions in Children and Young Adults With Inflammatory Bowel Disease and Influence on Health
This completed trial update reports on the risk of various mental health conditions among children and young adults with inflammatory bowel …
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Mechanisms of Transcutaneous Auricular Vagus Nerve Stimulation in Depression [NA]
A clinical trial investigates the mechanisms of transcutaneous auricular vagus nerve stimulation for depressive disorders and is currently r…
-
FDA approval · 2025-06-11FDA Approved: OLANZAPINE INTRAMUSCULAR — Original Application (UBI Pharma Inc.)
The FDA approved the intramuscular olanzapine generic from UBI Pharma Inc. under an Original Application, for use in agitation associated wi…
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Investigation of Factors Associated With Preserved Cognitive Function in Bipolar Disorder
Clinical trial investigating factors linked to preserved cognitive function in individuals with bipolar disorder; currently active but not r…
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: Effectiveness of mHealth Post-discharge Intervention for Patients With Severe Mental Illness [NA]
This clinical trial update notes that enrollment is ongoing by invitation for a study evaluating a mobile health post-discharge intervention…
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Bipolar Disorder
ProgenaBiome's non-interventional pilot study investigating the role of gut flora in bipolar disorder has been withdrawn.
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: App and Body Fat Scale in the Management of Overweight Patients [NA]
Trial status update for a study evaluating an app and body fat scale to manage overweight in patients with schizophrenia or bipolar disorder…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Survey on the Reproductive and Child-Rearing Situations of Patients With Severe Mental Disorders
This clinical trial update reports the completion of a survey examining reproductive and child-rearing situations among adults with severe m…
-
FDA approval · 2025-05-27FDA Approved: ASENAPINE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for asenapine submitted by Alembic Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2025-05-25Clinical Trial Update: Tai Chi/Qigong for Subsyndromal Depression and Cognition in Older Age Bipolar Disorder [NA]
This is a completed clinical trial evaluating Tai Chi/Qigong as an intervention for subsyndromal depression and cognition in older adults wi…
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: Mindfulness Psychoeducation for Bipolar Disorder Caregivers' Mindfulness, Burden, Quality of Life and Resilience [NA]
A clinical trial evaluating a mindfulness psychoeducation program for caregivers of individuals with bipolar disorder. The study will assess…